Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder.
Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials. 2012 Jul; 33(4):666-78.